ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.06
+0.12 (2.43%)
At close: Dec 18, 2025, 4:00 PM EST
5.08
+0.02 (0.40%)
After-hours: Dec 18, 2025, 5:59 PM EST
ENDRA Life Sciences Market Cap
ENDRA Life Sciences has a market cap or net worth of $5.9 million as of December 18, 2025. Its market cap has increased by 101.15% in one year.
Market Cap
5.90M
Enterprise Value
5.47M
1-Year Change
101.15%
Ranking
Category
Stock Price
$5.06
Market Cap Chart
Since June 30, 2017, ENDRA Life Sciences's market cap has decreased from $15.15M to $5.90M, a decrease of -61.05%. That is a compound annual growth rate of -10.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 5.76M | 71.44% |
| Dec 31, 2024 | 3.36M | -81.25% |
| Dec 29, 2023 | 17.92M | 39.49% |
| Dec 30, 2022 | 12.85M | -55.92% |
| Dec 31, 2021 | 29.15M | 15.68% |
| Dec 31, 2020 | 25.20M | 100.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |